LYMPHOHISTIOCYTOSIS

Clinical trials for LYMPHOHISTIOCYTOSIS explained in plain language.

Never miss a new study

Get alerted when new LYMPHOHISTIOCYTOSIS trials appear

Sign up with your email to follow new studies for LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug duo targets persistent 'Mono' virus in adults

Disease control Recruiting now

This study is testing whether a combination of two drugs, golidocitinib and selinexor, can help control chronic active Epstein-Barr virus disease (CAEBVD) in adults. The goal is to reduce the amount of virus in the blood and improve disease symptoms. It is for adults aged 18-70 w…

Matched conditions: LYMPHOHISTIOCYTOSIS

Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

LYMPHOHISTIOCYTOSIS

Get alerted when new LYMPHOHISTIOCYTOSIS trials appear

New drug duo targets persistent 'Mono' virus in adults